Allergic Rhinitis
Conditions
Interventions
Control group: loratadine+Nasal glucocorticoid Mometasone furoate nasal spray
Experimental group: loratadine+Nasal glucocorticoid Mometasone furoate nasal spray+Acupoint Massage+Thunder fire moxibustion
Sponsors
Sinopharm Tongmei General Hospital
Eligibility
Sex/Gender
All
Age
23 Years to 44 Years
Inclusion criteria
Inclusion criteria: The patients had typical symptoms of allergic rhinitis, such as paroxysmal sneezing, watery nose, nasal congestion, nasal itching, etc., and the cumulative duration of symptoms exceeded 1 hour/day, and the course of disease lasted for more than 4 weeks. Nasal examination showed that the nasal mucosa was pale and edema, and there were watery secretions in the nasal cavity
Exclusion criteria
Exclusion criteria: Exclusion criteria were patients with severe cardiovascular and cerebrovascular diseases, liver and kidney insufficiency, blood system diseases, mental diseases, pregnant or lactating women, patients who had received immunotherapy or used glucocorticoid nasal spray within the past 1 month, patients with abnormal nasal anatomy and severe deviation of nasal septum that affected the evaluation of treatment effect
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Nasal Symptom Scores;TCM Symptom Scores;Clinical Efficacy;Rhinoconjunctivitis Quality of Life Questionnaire; | — |
Secondary
| Measure | Time frame |
|---|---|
| BMI;Age;Gender;Patient Satisfaction;Compliance ;Adverse Reaction Incidence; | — |
Countries
China
Contacts
Public ContactXia Wu
Sinopharm Tongmei General Hospital
Outcome results
None listed